EBS Emergent BioSolutions Inc.
$8.24▲ +3.65%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$425.15M
P/E Ratio
–
Div Yield
–%
52W Range
5.62 - 14.06
% vs 50 MA
-5.43%
% vs 200 MA
-18.26%
RSI-14
42.7
MACD Histogram
-0.0800
Beta (1Y vs SPY)
1.68
Free Cash Flow
-$36.20M
Gross Rev
$149.70M
Gross Profit
$77.70M
EBITDA
$47.90M
COGS
$72.00M
Operating Exp
$67.20M
Operating Income
$10.50M
EBIT
$10.50M
Pretax Income
$13.40M
Net Income
$6.80M
EPS (Diluted)
0.07
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Mar 2026 (Quarterly)
Social Sentiment
Avg +0.42 · 6 posts
NewsTradeConnecticut's first case of clade I mpox + ANDV virus
r/stocks · May 14, 2026
The author anticipates a surge in EBS stock due to the mpox vaccine demand.
positive
+0.80
DDTradeDiscussionHantavirus portfolio
r/stocks · May 8, 2026
The author believes EBS will perform well due to historical trends and a valuable 'national security' moat.
positive
+0.70
DDPriceTargetA1 Releases September's 5 most undervalued stocks
r/wallstreetbets · Sep 2, 2024
Presented as an undervalued stock with potential upside.
positive
+0.60
Sunk Cost Fallacy
r/stocks · Aug 26, 2024
The user is admitting to a significant loss on EBS and considering cutting losses, indicating negative sentiment.
negative
-0.60
NewsDiscussionW.H.O. Declares Global Emergency Over New Mpox Outbreak
r/investing · Aug 14, 2024
Volatility is expected due to the news, suggesting potential upside for companies involved in vaccine production.
positive
+0.60
Page 1 of 2 (6 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.